|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Washington CR, Haggerty A, Ronner W, Neff
PM and Ko EM: Knowledge of endometrial cancer risk factors in a
general gynecologic population. Gynecol Oncol. 158:137–142. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Byrne FL, Martin AR, Kosasih M, Caruana BT
and Farrell R: The role of hyperglycemia in endometrial cancer
pathogenesis. Cancers (Basel). 12:11912020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagao S: IV. Endometrial Cancer. Gan To
Kagaku Ryoho. 47:247–251. 2020.(In Japanese). PubMed/NCBI
|
|
5
|
Lamothe S and Ramia de Cap M: Survival
analysis and treatment effects in patients with endometrial cancer
and POLE mutations. Cancer. 127:4306–4307. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luna C, Balcacer P, Castillo P, Huang M
and Alessandrino F: Endometrial cancer from early to advanced-stage
disease: An update for radiologists. Abdom Radiol (NY).
46:5325–5336. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deng L, Meng T, Chen L, Wei W and Wang P:
The role of ubiquitination in tumorigenesis and targeted drug
discovery. Signal Transduct Target Ther. 5:112020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pérez-Benavente B, Nasresfahani AF and
Farràs R: Ubiquitin-regulated cell proliferation and cancer. Adv
Exp Med Biol. 1233:3–28. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Faktor J, Pjechová M, Hernychová L and
Vojtěšek B: Protein ubiquitination research in oncology. Klin
Onkol. 32 (Suppl 3):S56–S64. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan Q, Wang Q, Cai R, Yuan H and Xu M: The
ubiquitin system: orchestrating cellular signals in non-small-cell
lung cancer. Cell Mol Biol Lett. 25:12020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang Q, Li F, Cheng Z, Kong Y and Chen C:
The role of E3 ubiquitin ligase HECTD3 in cancer and beyond. Cell
Mol Life Sci. 77:1483–1495. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Zurlo G and Zhang Q: The roles of
Cullin-2 E3 ubiquitin ligase complex in cancer. Adv Exp Med Biol.
1217:173–186. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Venuto S and Merla G: E3 ubiquitin ligase
TRIM proteins, cell cycle and mitosis. Cells. 8:5102019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang ZW, Hu X, Ye M, Lin M, Chu M and Shen
X: NEDD4 E3 ligase: Functions and mechanism in human cancer. Semin
Cancer Biol. 67:92–101. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Katoh M and Katoh M: Identification and
characterization of PDZRN3 and PDZRN4 genes in silico. Int J Mol
Med. 13:607–613. 2004.PubMed/NCBI
|
|
16
|
Ko JA, Kimura Y, Matsuura K, Yamamoto H,
Gondo T and Inui M: PDZRN3 (LNX3, SEMCAP3) is required for the
differentiation of C2C12 myoblasts into myotubes. J Cell Sci.
119:5106–5113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marracci S, Vangelisti A, Raffa V,
Andreazzoli M and Dente L: pdzrn3 is required for pronephros
morphogenesis in Xenopus laevis. Int J Dev Biol. 60:57–63. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marunaka K, Furukawa C, Fujii N, Kimura T,
Furuta T, Matsunaga T, Endo S, Hasegawa H, Anzai N, Yamazaki Y, et
al: The RING finger- and PDZ domain-containing protein PDZRN3
controls localization of the Mg2+ regulator claudin-16
in renal tube epithelial cells. J Biol Chem. 292:13034–13044. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sewduth RN, Jaspard-Vinassa B, Peghaire C,
Guillabert A, Franzl N, Larrieu-Lahargue F, Moreau C, Fruttiger M,
Dufourcq P, Couffinhal T and Duplàa C: The ubiquitin ligase PDZRN3
is required for vascular morphogenesis through Wnt/planar cell
polarity signaling. Nat Commun. 5:48322014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nikolaou S and Machesky LM: The stressful
tumour environment drives plasticity of cell migration programmes,
contributing to metastasis. J Pathol. 250:612–623. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jamil A and Kasi A: Lung Metastasis.
StatPearls (Internet). StatPearls Publishing; Treasure Island, FL:
2021
|
|
24
|
Lu C, Ning G, Si P, Zhang C, Liu W, Ge W,
Cui K, Zhang R and Ge S: E3 ubiquitin ligase HECW1 promotes the
metastasis of non-small cell lung cancer cells through mediating
the ubiquitination of Smad4. Biochem Cell Biol. 99:675–681. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen J, Yu Z and Li N: The E3 ubiquitin
ligase RNF146 promotes colorectal cancer by activating the
Wnt/β-catenin pathway via ubiquitination of Axin1. Biochem Biophys
Res Commun. 503:991–997. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Honda T and Inui M: PDZRN3 regulates
differentiation of myoblasts into myotubes through transcriptional
and posttranslational control of Id2. J Cell Physiol.
234:2963–2972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Honda T and Inui M: PDZRN3 protects
against apoptosis in myoblasts by maintaining cyclin A2 expression.
Sci Rep. 10:11402020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sewduth RN, Kovacic H, Jaspard-Vinassa B,
Jecko V, Wavasseur T, Fritsch N, Pernot M, Jeaningros S, Roux E,
Dufourcq P, et al: PDZRN3 destabilizes endothelial cell-cell
junctions through a PKCζ-containing polarity complex to increase
vascular permeability. Sci Signal. 10:eaag32092017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chatterjee A, Paul S, Bisht B,
Bhattacharya S, Sivasubramaniam S and Paul MK: Advances in
targeting the WNT/β-catenin signaling pathway in cancer. Drug
Discov Today. Jul 10–2021.(Epub ahead of print).
|
|
30
|
Fatima I, Barman S, Rai R, Thiel KWW and
Chandra V: Targeting Wnt signaling in endometrial cancer. Cancers
(Basel). 13:23512021. View Article : Google Scholar : PubMed/NCBI
|
